Related Experiment Video
Updated: Jan 19, 2026
04:36
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
6.6K
Peripartum Cardiomyopathy: A Review
Lindsay C Ballard1, Adrian Cois2, Bory Kea3
1Department of Emergency Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon 97239-3098.
Current Emergency and Hospital Medicine Reports
|September 20, 2019
Summary
Peripartum cardiomyopathy (PPCM) is a serious heart condition affecting women during pregnancy or postpartum. Research highlights genetic factors and hormonal imbalances as potential causes, with ongoing efforts to improve diagnosis and management.
Area of Science:
- Cardiology
- Genetics
- Obstetrics
Background:
- Peripartum cardiomyopathy (PPCM) is a significant cause of maternal morbidity and mortality globally.
- Patients with PPCM face a high risk of long-term cardiac complications requiring ongoing medical care.
Purpose of the Study:
- To review recent literature on Peripartum cardiomyopathy (PPCM).
- To provide insights into the etiology, diagnosis, and management of PPCM.
Main Methods:
- Literature review of recent studies on Peripartum cardiomyopathy.
- Analysis of genetic, hormonal, and vascular research related to PPCM.
Main Results:
- Genetic markers such as TTNC1, TTN, and STAT3 show prevalence in PPCM patients.
- Imbalances in angiogenesis, influenced by placental angiogenic factors and genetic mutations, are implicated as a primary etiology.
- Current biomarkers are insufficient to distinguish PPCM from other heart failure types.
Conclusions:
- Women diagnosed with PPCM have increased risks of cesarean sections, hypertensive disorders, and major adverse cardiac events.
- PPCM is associated with lifelong morbidity for affected women.
- Further research is needed to develop specific biomarkers for PPCM.
